Perrigo Company PLC
NYSE:PRGO

Watchlist Manager
Perrigo Company PLC Logo
Perrigo Company PLC
NYSE:PRGO
Watchlist
Price: 24.62 USD 2.37%
Market Cap: 3.4B USD

Relative Value

The Relative Value of one PRGO stock under the Base Case scenario is 84.57 USD. Compared to the current market price of 24.62 USD, Perrigo Company PLC is Undervalued by 71%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PRGO Relative Value
Base Case
84.57 USD
Undervaluation 71%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
92
vs Industry
74
Median 3Y
1
Median 5Y
1.1
Industry
2.5
Forward
0.7
vs History
vs Industry
Median 3Y
-45
Median 5Y
-32.2
Industry
20.8
Forward
9.1
vs History
50
vs Industry
36
Median 3Y
14.6
Median 5Y
13.6
Industry
15.9
vs History
77
vs Industry
25
Median 3Y
10.2
Median 5Y
10.5
Industry
22.8
vs History
92
vs Industry
67
Median 3Y
0.9
Median 5Y
0.9
Industry
2
vs History
85
vs Industry
61
Median 3Y
1.6
Median 5Y
1.8
Industry
2.5
Forward
1.4
vs History
92
vs Industry
48
Median 3Y
4.4
Median 5Y
5.1
Industry
5
vs History
73
vs Industry
31
Median 3Y
11.9
Median 5Y
12.7
Industry
13.3
Forward
8.6
vs History
68
vs Industry
14
Median 3Y
30.1
Median 5Y
32.6
Industry
16.3
Forward
10.9
vs History
39
vs Industry
24
Median 3Y
25.2
Median 5Y
23.2
Industry
14.9
vs History
28
vs Industry
19
Median 3Y
33.1
Median 5Y
30.6
Industry
18.6
vs History
92
vs Industry
67
Median 3Y
0.8
Median 5Y
0.8
Industry
1.8

Multiples Across Competitors

PRGO Competitors Multiples
Perrigo Company PLC Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
IE
Perrigo Company PLC
NYSE:PRGO
3.3B USD 0.8 -21 10.8 25.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
726.3B USD 17.7 86.6 46.7 52.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.6T DKK 9.5 27.2 18.9 21.6
US
Johnson & Johnson
NYSE:JNJ
352.7B USD 4 24 11.6 15.1
US
Merck & Co Inc
NYSE:MRK
244.7B USD 3.9 20.1 10.2 12.2
CH
Roche Holding AG
SIX:ROG
218B CHF 3.7 19 10.6 12.6
UK
AstraZeneca PLC
LSE:AZN
171.4B GBP 4.3 32.8 169.9 254.6
CH
Novartis AG
SIX:NOVN
176.6B CHF 3.9 11.1 9.6 13.4
US
Pfizer Inc
NYSE:PFE
148.7B USD 2.5 35.1 10.4 15.7
P/E Multiple
Earnings Growth PEG
IE
Perrigo Company PLC
NYSE:PRGO
Average P/E: 32
Negative Multiple: -21
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
86.6
76%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
27.2
23%
1.2
US
Johnson & Johnson
NYSE:JNJ
24
-8%
N/A
US
Merck & Co Inc
NYSE:MRK
20.1
320%
0.1
CH
Roche Holding AG
SIX:ROG
19
16%
1.2
UK
AstraZeneca PLC
LSE:AZN
32.8
40%
0.8
CH
Novartis AG
SIX:NOVN
11.1
9%
1.2
US
Pfizer Inc
NYSE:PFE
35.1
102%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IE
Perrigo Company PLC
NYSE:PRGO
Average EV/EBITDA: 414.5
10.8
10%
1.1
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
46.7
42%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
DK
Novo Nordisk A/S
CSE:NOVO B
18.9
22%
0.9
US
Johnson & Johnson
NYSE:JNJ
11.6
4%
2.9
US
Merck & Co Inc
NYSE:MRK
10.2
63%
0.2
CH
Roche Holding AG
SIX:ROG
10.6
7%
1.5
UK
AstraZeneca PLC
LSE:AZN
169.9
18%
9.4
CH
Novartis AG
SIX:NOVN
9.6
3%
3.2
US
Pfizer Inc
NYSE:PFE
10.4
9%
1.2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IE
Perrigo Company PLC
NYSE:PRGO
Average EV/EBIT: 1 812.5
25.8
33%
0.8
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
52.1
45%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
DK
Novo Nordisk A/S
CSE:NOVO B
21.6
22%
1
US
Johnson & Johnson
NYSE:JNJ
15.1
8%
1.9
US
Merck & Co Inc
NYSE:MRK
12.2
97%
0.1
CH
Roche Holding AG
SIX:ROG
12.6
9%
1.4
UK
AstraZeneca PLC
LSE:AZN
254.6
32%
8
CH
Novartis AG
SIX:NOVN
13.4
17%
0.8
US
Pfizer Inc
NYSE:PFE
15.7
19%
0.8